11β-hydroxysteroid dehydrogenase type I enzyme in the hearts of normotensive and spontaneously hypertensive rats

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 8, 1996, Pages 642-647

  Smith, R E ^a   Krozowski, Z S ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

11 hydroxysteroid dehydrogenase; Glucocorticoid; Heart; Mineralocorticoid

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOSTERONE; GLUCOCORTICOID;

ANIMAL EXPERIMENT; ARTICLE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HYPERTENSION; MALE; NONHUMAN; RAT; SEX DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0029833821     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb01750.x     Document Type: Article

References (53)

1. Krozowski ZS, Funder JW. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc. Nail Acad. Sci. USA 1983; 80: 6056-60.
2. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 1988; 242: 583-5.
3. Edwards CR, Stewart PM, Hurt D et al. Localisation of 11 betahydroxysteroid dehydrogenase: Tissue-specific protector of the mineralocorticoid receptor. Lancet 1988; ii: 986-9.
4. Ulick S, Levine SL, Gunczler P et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of Cortisol. J. Clin. Endocrinol Metab. 1979; 49: 757-63.
5. Ulick S, Tedde R, Wang JZ. Defective ring: A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 1992; 74: 593-9.
6. Watt GC, Harrap SB, Foy CJ et al. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: A four-corners approach to the identification of genetic determinants of blood pressure. J. Hyperlens. 1992; 10: 473-82.
7. Walker BR, Campbell JC, Williams BC, Edwards CR. Tissuespecific distribution of the NAD( + )-dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Endocrinology 1992; 131: 970-2.
8. Mercer WR, Krozowski ZS. Localization of an 11 beta hydroxysteroid dehydrogenase activity to the distal nephron. Evidence for the existence of two species of dehydrogenase in the rat kidney. Endocrinology 1992; 130: 540-3.
9. Rusvai E, Naray-Fejes-Toth A. A new isoform of 11-beta-hydroxysteroid dehydrogenase in aldosterone target cells. J. Biol. Chetn. 1993; 268: 10 717-20.
10. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 1994; 105: Rll-17.
11. Agarwal AK, Mune T, Monder C, White PC. Nad( + )-dependent isoform of 11 beta-hydroxysteroid dehydrogenase: Cloning and characterization of cDNA from sheep kidney. J. Biol. Chem. 1994; 269:25959-62.
12. Naray-Fejes-Toth A, Fejes-Toth G. Expression cloning of the aldosterone target cell-specific 11 beta-hydroxysteroid dehydrogenase from rabbit collecting duct cells. Endocrinology 1995; 136; 2579-86.
13. Zhou MY, Gomez-Sanchez EP, Cox DL, Cosby D, GomezSanchez CE. Cloning, expression and tissue distribution of the rat nicotinamide adenine dinucleotide-dependent 11 beta-hydroxysteroid dehydrogenase. Endocrinology 1995; 136: 3729-34.
14. Cole TJ. Cloning of the mouse 11 beta-hydroxysteroid dehydrogenase type 2 gene: Tissue-specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology 1995; 136: 4693-6.
15. Nikkila H, Tannin GM, New MI et al. Defects in the HSD11 gene encoding 11-beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. J. Clin. Endocrinol. Metab. 1993; 77: 687-91.
16. Wilson RC, Krozowski ZS, Li K el al. A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 1995; 80: 2263-6.
17. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nature Genetics 1995; 10: 394-9.
18. Wilson RC, Harbison MD, Krozowski ZS el ai. Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 1995; 80: 3145-50.
19. Obeyesekere VR, Ferrari P, Andrews RK et al. The R337C mutation generates a high Km 11 beta-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 1995; 80: 3381-3.
20. Krozowski Z, Maguire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK. Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J. Clin. Endocrinol. Metab. 1995; 80:2203-9.
21. Lombes M, Alfaidy N, Eugene E, Lessana A, Farman N, Bonvalet JP. Prerequisite for cardiac aldosterone action: Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart. Circulation 1995; 92: 175-82.
22. Pearce P, Funder J W. High affinity aldosterone binding sites (type I receptors) in rat heart. Clin. Exp. Pharmacol. Physiol. 1987; 14: 859-66.
23. Reul JM, Pearce PT, Funder JW, Krozowski ZS. Type I and type II corticosteroid receptor gene expression in the rat: Effect of adrenalectomy and dexamethasone administration. Mol. Endocrinol. 1989; 3: 1674-80.
24. Lombes M, Oblin ME, Gasc JM, Baulieu EE, Farman N, Bonvalet JP. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ. Res. 1992; 71: 503-10.
25. Walker BR, Yau JL, Brett LP et al. 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: Implications for cardiovascular responses to glucocorticoids. Endocrinology 1991; 129: 3305-12.
26. Slight S, Ganjam VK, Nonneman DJ, Weber KT. Glucocorticoid metabolism in the cardiac interstitium: 11-Beta-hydroxysteroid dehydrogenase activity in cardiac fibroblasts. J. Lab. Clin. Med. 1993; 122: 180-7.
27. Mercer W, Obeyesekere V, Smith R, Krozowski Z. Characterization of Il-beta-HSDlB gene expression and enzymatic activity. Mol. Cell. Endocrinol. 1993; 92: 247-51.
28. Brilla CG, Maisch B, Weber KT. Myocardial collagen matrix remodelling in arterial hypertension. EUT. Heart J. 1992; 13: 24-32.
29. Albiston AL, Smith RE, Krozowski ZS. Sex- and tissue-specific regulation of 11 beta-hydroxysteroid dehydrogenase mRNA. Mol. Cell. Endocrinol. 1995; 109: 183-8.
30. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein dye binding. Anal. Biochem. 1976; 72: 248-54.
31. Chirgwin JM, Pryzbyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically activity ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-9.
32. Krozowski Z, Obeyesekere V, Smith R, Mercer W. Tissue-specific expression of an 11 beta-hydroxysteroid dehydrogenase with a truncated N-terminal domain. A potential mechanism for differential intracellular localization within mineralocorticoid target cells. J. Biol. Chem. 1992; 267: 2569-74.
33. Agarwal AK, Monder C, Eckstein B, White PC. Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. J. Biol Chem. 1989; 264: 18939-46.
34. Krozowski Z, Stuchbery S, White P, Monder C, Funder JW. Characterization of 11 beta-hydroxysteroid dehydrogenase gene expression: Identification of multiple unique forms of messenger ribonucleic acid in the rat kidney. Endocrinology 1990; 127: 3009-13.
35. Moisan MP, Edwards CR, Seckl JR. Ontogeny of 11 betahydroxysteroid dehydrogenase in rat brain and kidney. Endocrinology 1992; 130: 400-4.
36. Monder C, Lakshmi V. Corticosteroid 11 beta-dehydrogenase of rat tissues: Immunological studies. Endocrinology 1990; 126: 2435-43.
37. Weber KT. Glucocorticoids and mineralocorticoids: Antifibrotic and profibrotic components of wound healing. J. Lab. Clin. Med. 1992; 120: 22-9.
38. Slight S, Ganjan VK, Nouneman D, Weber KT. Hydroxysteroid dehydrogenase activity in cultured cardiac fibroblasts versus endothelial cells. Clin. Res. 1992; 40: 683A.
39. Phillips DM, Lakshmi V, Monder C. Corticosteroid 11 betadehydrogenase in rat testis. Endocrinology 1989; 125: 209-16.
40. Neumann A, Haider SG, Hilscher B. Temporal coincidence of the appearance of elongated spermatids and of histochemical reaction of 11-beta-hydroxysteroid dehydrogenase in rat Leydig cells. Andrologia 1993; 25: 263-9.
41. Smith RE, Mercer WR, Provencher PH, Obeyesekere V, Krozowski ZS. The heterogeneity of 11-beta-hydroxysteroid dehydrogenase activities in the rat hippocampus implies a complex regulation of steroid hormone action. Clin. Exp. Pharmacol. Physiol. 1992; 19: 365-8.
42. Hashimoto K, Makino S, Hirasawa R et öl. Abnormalities in the hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats during development of hypertension. Endocrinology 1989; 125: 1161-7.
43. Yagil Y, Levin M, Krakoff LR. Effect of glucocorticoid deficiency on arterial pressure in conscious spontaneously hypertensive rats. Am. J. Hypenens. 1989; 2: 99-104.
44. Stewart PM, Whorwood CB, Valentino R, Burt D, Sheppard MC, Edwards C. 11-Beta-hydroxysteroid dehydrogenase activity and gene expression in the hypertensive Bianchi-Milan rat. J. Hypertension 1993; 11: 349-54.
45. Davidson AO, Schork N, Jaques BC et al. Blood pressure in genetically hypertensive rats. Influence of the Y chromosome. Hypertension 1995; 26:452-9.
46. Tannin GM, Agarwal AK, Monder C, New MI, White PC. The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. J. Biol. Chem. 1991; 26: 16653-8.
47. Schirner M, Taube C. U 46619 induces different blood pressure effects in male and female spontaneously hypertensive rats (SHR). Prostaglandins Leukot. Essent. Fatty Acids 1993; 48: 469-73.
48. Albiston AL, Smith RE, Krozowski ZS. Changes in the levels of 11 beta-hydroxysteroid dehydrogenase mRNA over the oestrous cycle in the rat. J. Steroid Biochem. Mol. Biol. 1995; 52: 45-8.
49. Ghraf R, Lax ER, Hoff GH, Schriefers H. The role of the gonads and the hypophysis in the regulation of hydroxysteroid dehydrogenase activities in rat kidney. Hoppe Seyler's Z. Physiol. Chem. 1975; 356: 135-42.
50. Low SC, Assaad SN, Rajan V, Chapman KE, Edwards C, Seckl JR. Regulation of 11 beta-hydroxysteroid dehydrogenase by sex steroids in vivo: Further evidence for the existence of a second dehydrogenase in rat kidney. J. Endocrinol. 1993; 139: 27-35.
51. Laux M, Bauer H, Ganten U, Zimmerman F, Vecsei P. Glucocorticoid receptors and dissociation constant (Kd) are decreased in mononuclear leukocytes of spontaneously hypertensive rats (S H RSP) as compared to normotensive Wistar-Kyoto rats (WKY). J. Steroid Biochem. 1989; 34: 331 -42.
52. Li SJ, Wong SC, Ingenito AJ. A low hippocampal dynorphin A (1-8) immunoreactivity in spontaneously hypertensive rats. Neuropeptides 1989; 13: 197-200.
53. Rubattu S, Volpe M, Enea I, Russo R, Romano M, Trimarco B. Influence of hypercholesterolemia on adrenal steroid metabolism and electrolyte balance in spontaneously hypertensive rats. Endocrinology 1993; 133: 2015-21.